USANA Health Sciences Inc. (USNA) said it increased its outlook for 2021, which now reflects top-line growth between 9.3% and 12.8%. Notably, it expects sales to accelerate during the second quarter, due largely to a short-term sales program it is offering around the world during the quarter.
The company offered a similar short-term sales program during the third quarter of 2020, which was successful and received a positive response from Associates around the world. Following the conclusion of the program, the company expects to see year-over-year sales growth, albeit at a decreased growth rate from the second quarter of this year.
The company raised its annual earnings per share to a range of $6.15 - $6.50 from the prior estimation of $6.00 - $6.45.
The company increased its annual net sales to a range of $1.24 billion - $1.28 billion from the previous outlook of $1.21 billion - $1.27 billion.
Analysts polled by Thomson Reuters expect the company to report earnings of $6.28 per share and revenues of $1.24 billion for fiscal year 2021. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.